LON:ABCAbcam Share Price, Forecast & News

Abcam's stock was trading at GBX 1,140 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ABC shares have increased by 16.8% and is now trading at GBX 1,332. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Abcam.

Abcam announced a dividend on Monday, March 9th. Shareholders of record on Thursday, March 19th will be paid a dividend of GBX 3.55 per share on Friday, April 17th. This represents a yield of 0.31%. The ex-dividend date is Thursday, March 19th. The official announcement can be viewed at this link. View Abcam's dividend history.

6 Wall Street analysts have issued 1-year target prices for Abcam's shares. Their forecasts range from GBX 1,220 to GBX 1,450. On average, they anticipate Abcam's share price to reach GBX 1,346 in the next year. This suggests a possible upside of 1.1% from the stock's current price. View analysts' price targets for Abcam.

News coverage about ABC stock has trended negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Abcam earned a news impact score of -2.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news about Abcam.

Some companies that are related to Abcam include Vir Biotechnology (VIR), MorphoSys (MOR), MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (MOR), MorphoSys (MOR), BTG (BTG), Cronos Group (CRON), Kodiak Sciences (KOD), Genus (GNS), Viela Bio (VIE), Mesoblast (MSB), Polynovo (PNV), NGM Biopharmaceuticals (NGM), Concordia International (CXR), Clinuvel Pharmaceuticals (CUV) and BELLUS Health (BLU). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), HSBC (HSBA), Centrica (CNA) and Marks and Spencer Group (MKS).

Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."

Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of ABC stock can currently be purchased for approximately GBX 1,332.

Abcam has a market capitalization of £2.88 billion and generates £273.40 million in revenue each year. Abcam employs 1,100 workers across the globe.

The official website for Abcam is www.abcam.com.

Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.